Interpace Diagnostics Group Reports Fourth Quarter and Full Year 2017 Financial Results Genetics Investing
Solid Biosciences Announces Clinical Hold On SGT-001 Phase I/II Clinical Trial For Duchenne Muscular Dystrophy Genetics Investing
Immune Design Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Corporate Update Genetics Investing
Otonomy Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Corporate Update Genetics Investing
OncoMed Announces Fourth Quarter and Full Year 2017 Financial Results and Operational Highlights Pharmaceutical Investing